These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 38855155)
1. Exosomal microRNAs in hepatocellular carcinoma, expanding research field. Zheng BH; Ni XJ; Liu HB World J Gastroenterol; 2024 May; 30(20):2618-2620. PubMed ID: 38855155 [TBL] [Abstract][Full Text] [Related]
2. EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p. Yi J; Ye Z; Xu H; Zhang H; Cao H; Li X; Wang T; Dong C; Du Y; Dong S; Zhou W Phytomedicine; 2024 Dec; 135():156137. PubMed ID: 39566403 [TBL] [Abstract][Full Text] [Related]
3. Integrating multi-omics techniques and Li Y; Chen Y; Zhang Y; Fang Y; Wu L; Zhao Y; Wang D; Qiao X Front Immunol; 2024; 15():1496886. PubMed ID: 39654899 [TBL] [Abstract][Full Text] [Related]
4. PIWIL genes in hepatocellular carcinoma: a multi-omics approach uncovering dysregulated expression and ceRNA networks in mice. Huang H; Lu R; Peng S; Huang S; Mo Y; Li G BMC Genom Data; 2024 Nov; 25(1):101. PubMed ID: 39604866 [TBL] [Abstract][Full Text] [Related]
5. Single-cell transcriptomics reveals tumor microenvironment changes and prognostic gene signatures in hepatocellular carcinoma. Wu Y; Zhai Y; Ding Z; Xie T; Zhu W; Zhang C; Lu Y; Chen Y; Ren S; Hu Y; Li X; Zhong F; Liang Y; Wang S Int Immunopharmacol; 2024 Dec; 143(Pt 2):113317. PubMed ID: 39447409 [TBL] [Abstract][Full Text] [Related]
6. Exosomal noncoding RNA (ncRNA) in breast cancer pathogenesis and therapy; two sides of the same coin. Ibrahim FM; Saleh RO; Uinarni H; Bokov DO; Menon SV; Zarifovich KB; Misra N; Al-Hamdani MM; Husseen B; Jawad MA Exp Cell Res; 2025 Jan; 444(1):114359. PubMed ID: 39608481 [TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4. Yang X; Sun L; Wang L; Yao B; Mo H; Yang W Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291 [TBL] [Abstract][Full Text] [Related]
9. HK3: A potential prognostic biomarker with metastasis inhibition capabilities in hepatocellular carcinoma. Du Y; Zhang H; Liu J; Duan X; Chen S; Jiang W Biochem Biophys Res Commun; 2024 Dec; 741():151057. PubMed ID: 39615209 [TBL] [Abstract][Full Text] [Related]
10. Unraveling the Heterogeneity of Tumor Immune Microenvironment in Hepatocellular Carcinoma by SingleCell RNA Sequencing and its Implications for Prognosis and Therapeutic Response. Han Y; Song L; Lv L; Fan C; Ding H Turk J Gastroenterol; 2024 Nov; 35(12):876-888. PubMed ID: 39641225 [TBL] [Abstract][Full Text] [Related]
11. The role of differentially expressed genes and immune cell infiltration in the progression of nonalcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): a new exploration based on bioinformatics analysis. Liu Y; Yu X; Wang Y; Wu J; Feng B; Li M Nucleosides Nucleotides Nucleic Acids; 2024; 43(12):1415-1430. PubMed ID: 38319987 [TBL] [Abstract][Full Text] [Related]
12. Transcription factor Zhang H; Zong R; Wu H; Jiang J; Liu C; Liu S Biomol Biomed; 2024 Oct; 24(6):1606-1619. PubMed ID: 38780447 [TBL] [Abstract][Full Text] [Related]
13. Exosomal miR-21-5p derived from endometrial stromal cells promotes angiogenesis by targeting TIMP3 in ovarian endometrial cysts. Sun L; Cheng Y; Wang J; Wu D; Yuan L; Wei X; Li Y; Gao J; Zhang G J Mol Med (Berl); 2024 Nov; 102(11):1327-1342. PubMed ID: 39227403 [TBL] [Abstract][Full Text] [Related]
14. Next-Cell Hypothesis: Mechanism of Obesity-Associated Carcinogenesis. Engin AB; Engin A Adv Exp Med Biol; 2024; 1460():727-766. PubMed ID: 39287871 [TBL] [Abstract][Full Text] [Related]
15. Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma. Chen A; Zhang VX; Zhang Q; Sze KM; Tian L; Huang H; Wang X; Lee E; Lu J; Lyu X; Lee MJ; Wong CM; Ho DW; Ng IO Gut; 2024 Dec; 74(1):90-102. PubMed ID: 38839271 [TBL] [Abstract][Full Text] [Related]
16. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression. Liu G; Guo W; Rao M; Qin J; Hu F; Li K Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110 [TBL] [Abstract][Full Text] [Related]
17. The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance. Tavakoli Pirzaman A; Alishah A; Babajani B; Ebrahimi P; Sheikhi SA; Moosaei F; Salarfar A; Doostmohamadian S; Kazemi S Technol Cancer Res Treat; 2024; 23():15330338241239188. PubMed ID: 38634139 [TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of multi-omics data identified PLG as key gene related to Anoikis resistance and immune phenotypes in hepatocellular carcinoma. Wang X; Gao L; Li H; Ma Y; Wang B; Gu B; Li X; Xiang L; Bai Y; Ma C; Chen H J Transl Med; 2024 Dec; 22(1):1104. PubMed ID: 39633373 [TBL] [Abstract][Full Text] [Related]
19. Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression. Luo C; Xin H; Zhou Z; Hu Z; Sun R; Yao N; Sun Q; Borjigin U; Wu X; Fan J; Huang X; Zhou S; Zhou J Hepatology; 2022 Oct; 76(4):982-999. PubMed ID: 35106794 [TBL] [Abstract][Full Text] [Related]
20. Long Non-coding RNA 02298 Promotes the Malignancy of HCC by Targeting the miR-28-5p/CCDC6 Pathway. Wang J; Xu B; Liang L; Chen Q Biochem Genet; 2024 Dec; 62(6):4967-4986. PubMed ID: 38381357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]